Unknown

Dataset Information

0

Efficacy of eculizumab in refractory life-threatening warm autoimmune hemolytic anemia associated with chronic myelomonocytic leukemia.


ABSTRACT: Eculizumab may be considered as an emergency therapeutic option in refractory life-threatening warm autoimmune hemolytic anemia especially if direct antiglobulin test is positive for both IgG and C3d and after failure of all conventional treatments.

SUBMITTER: Gauchy AC 

PROVIDER: S-EPMC7752594 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Efficacy of eculizumab in refractory life-threatening warm autoimmune hemolytic anemia associated with chronic myelomonocytic leukemia.

Gauchy Anne-Cécile AC   Hentzien Maxime M   Wynckel Alain A   de Marcellus Victoire V   Rodier Cyrielle C   Delmer Alain A   Quinquenel Anne A  

Clinical case reports 20200817 12


Eculizumab may be considered as an emergency therapeutic option in refractory life-threatening warm autoimmune hemolytic anemia especially if direct antiglobulin test is positive for both IgG and C3d and after failure of all conventional treatments. ...[more]

Similar Datasets

| S-EPMC6224177 | biostudies-literature
| S-EPMC5803969 | biostudies-literature
| S-EPMC6246027 | biostudies-literature
| S-EPMC7796467 | biostudies-literature
| S-EPMC3311724 | biostudies-literature
| S-EPMC8593301 | biostudies-literature
| S-EPMC8110228 | biostudies-literature
| S-EPMC7677104 | biostudies-literature